Enzene Biosciences
India - PuneBiotechnology
Focus: Enzene Biosciences is an India-based biotech company specializing in biosimilars and peptide therapeutics, targeting ophthalmology, neurology, and gastroenterology indications. The company operates at clinical-stage with Phase 1 and Phase 3 programs in development.
Profile data last refreshed 14h ago · AI intelligence enriched 2w ago
Open Jobs
1-3 this month
Stable — net -3 jobs in 30d
1 added, 4 removed. Backfill posture.
Should You Work at Enzene Biosciences?
AI assessmentEnzene is a speculative early-stage opportunity best suited for risk-tolerant scientists seeking deep technical work in peptides/biosimilars; hiring freeze and opaque financials make it a secondary choice versus funded clinical-stage peers.
Why Work Here
- Early-stage company with Phase 3 catalyst (ENZ215 in postmenopausal osteoporosis) that could generate clinical data within 12–24 months.
Data completeness
3/9 — Basic
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
ENZ215
Healthy Male SubjectsClinical Trials (1)
NCT05245669Study to Compare the Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Immunogenicity of Biosimilar Denosumab With Prolia® in Healthy Adult Male Volunteers
Phase 1Help build intelligence for Enzene Biosciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.